Variables That Affect Success in Debate

This study examines the effect of the six traditional categories of debate evaluation on the A.F.A. Form C and Form W ballots upon win/loss and gender. It also examines the effect of nonperformance variables, such as proximity, gender of the debaters, and gender of the judge, upon the outcome of intercollegiate debates. The data were gathered from the Owen L. Coon Memorial Debate Tournament hosted by Northwestern University in February, 1983. In all, the data pool consisted of 42 debates. The data were submitted to analysis to the SAS computer program at Eastern Illinois University. The results of the discriminant analysis indicated that winners and losers could be classified according to analysis, reasoning, evidence, organization, refutation, and delivery over 60% of the time. The results of a t-test indicated that there was no significant difference, however, in relation to scoring on delivery between winners and losers. The results of the discriminant analysis of the gender dependent measure indicates that the categories predict gender less than 60% of the time. The t-test showed there was no significant difference in regard to the six categories with the exception of delivery in which females scored higher. An analysis of variance was performed upon the dependent measure decision. The results indicated that there is an interaction of composition of the team and proximity of the team to the judge that affects the outcome in intercollegiate debate. The analysis of variance performed upon the dependent measure of team rating points found that there was an interaction of composition, proximity, and, in this instance, gender of the judge. This indicates that nonperformance variables are a factor in the outcome of a debate, as well as the traditional categories of evaluation

Variables That Affect Success in Debate

This study examines the effect of the six traditional categories of debate evaluation on the A.F.A. Form C and Form W ballots upon win/loss and gender. It also examines the effect of nonperformance variables, such as proximity, gender of the debaters, and gender of the judge, upon the outcome of intercollegiate debates. The data were gathered from the Owen L. Coon Memorial Debate Tournament hosted by Northwestern University in February, 1983. In all, the data pool consisted of 42 debates. The data were submitted to analysis to the SAS computer program at Eastern Illinois University. The results of the discriminant analysis indicated that winners and losers could be classified according to analysis, reasoning, evidence, organization, refutation, and delivery over 60% of the time. The results of a t-test indicated that there was no significant difference, however, in relation to scoring on delivery between winners and losers. The results of the discriminant analysis of the gender dependent measure indicates that the categories predict gender less than 60% of the time. The t-test showed there was no significant difference in regard to the six categories with the exception of delivery in which females scored higher. An analysis of variance was performed upon the dependent measure decision. The results indicated that there is an interaction of composition of the team and proximity of the team to the judge that affects the outcome in intercollegiate debate. The analysis of variance performed upon the dependent measure of team rating points found that there was an interaction of composition, proximity, and, in this instance, gender of the judge. This indicates that nonperformance variables are a factor in the outcome of a debate, as well as the traditional categories of evaluation

Epithelial cell-directed efferocytosis in the post-partum mammary gland is necessary for tissue homeostasis and future lactation

<p>Abstract</p> <p>Background</p> <p>Mammary glands harbor a profound burden of apoptotic cells (ACs) during post-lactational involution, but little is known regarding mechanisms by which ACs are cleared from the mammary gland, or consequences if this process is interrupted. We investigated AC clearance, also termed efferocytosis, during post-lactational remodeling, using mice deficient for MerTK, Axl, and Tyro3, three related receptor tyrosine kinases (RTKs) regulating macrophage-mediated efferocytosis in monocytes. MerTK expression, apoptosis and the accumulation of apoptotic debris were examined in histological sections of MerTK-deficient, Axl/Tyro3-deficient, and wild-type mammary glands harvested at specific time points during lactation and synchronized involution. The ability of primary mammary epithelial cells (MECs) to engulf ACs was assessed in culture. Transplant of MerTK-deficient mammary epithelium into cleared WT mammary fat pads was used to assess the contribution of WT mammary macrophages to post-lactational efferocytosis.</p> <p>Results</p> <p>ACs induced MerTK expression in MECs, resulting in elevated MerTK levels at the earliest stages of involution. Loss of MerTK resulted in AC accumulation in post-lactational MerTK-deficient mammary glands, but not in Axl and Tyro3-deficient mammary glands. Increased vascularization, fibrosis, and epithelial hyperproliferation were observed in MerTK-deficient mammary glands through at least 60 days post-weaning, due to failed efferocytosis after lactation, but did not manifest in nulliparous mice. WT host-derived macrophages failed to rescue efferocytosis in transplanted MerTK-deficient mammary epithelium.</p> <p>Conclusion</p> <p>Efferocytosis by MECs through MerTK is crucial for mammary gland homeostasis and function during the post-lactational period. Efferocytosis by MECs thus limits pathologic consequences associated with the apoptotic load following lactation.</p

ErbB4/HER4: Role in Mammary Gland Development, Differentiation and Growth Inhibition

The ErbB receptor tyrosine kinase family has often been associated with increased growth of breast epithelial cells, as well as malignant transformation and progression. In contrast, ErbB4/HER4 exhibits unique attributes from a two step proteolytic cleavage which releases an 80 kilodalton, nuclear localizing, tyrosine kinase to a signal transduction mechanism that slows growth and stimulates differentiation of breast cells. This review provides an overview of ErbB4/HER4 in growth and differentiation of the mammary epithelium, including its physiologic role in development, the contrasting growth inhibition/tumor suppression and growth acceleration of distinct ErbB4/HER4 isoforms and a description of the unique cell cycle regulated pattern of nuclear HER4 ubiquitination and destruction

HER4 D-Box Sequences Regulate Mitotic Progression and Degradation of the Nuclear HER4 Cleavage Product s80HER4

Heregulin-mediated activation of HER4 initiates receptor cleavage (releasing an 80-kDa HER4 intracellular domain, s80HER4, containing nuclear localization sequences) and results in G2/M delay by unknown signaling mechanisms. We report herein that s80HER4 contains a functional cyclin B-like sequence known as a D-box, which targets proteins for degradation by APC/C, a multisubunit ubiquitin ligase. s80HER4 ubiquitination and ptoteosomal degradation occurred during mitosis but not during S-phase. Inhibition of an APC subunit (APC2) using siRNA knock-down impaired s80HER4 degradation. Mutation of the s80HER4 D-box sequence stabilized s80HER4 during mitosis, and s80HER4-dependent growth inhibition via G2/M delay was significantly greater with the D-box mutant. Polyomvirus middle-T antigen-transformed HC11 cells expressing s80HER4 resulted in smaller, less proliferative, more differentiated tumors in vivo than those expressing kinase-dead s80HER4 or the empty vector. Cells expressing s80HER4 with a disrupted D-box did not form tumors, instead forming differentiated ductal structures. These results suggest that cell cycle-dependent degradation of s80HER4 limits its growth inhibitory action, and stabilization of s80HER4 enhances tumor suppression, thus providing a link between HER4-mediated growth inhibition and cell cycle control

An evaluation of emerging feed additives to reduce methane emissions from livestock

The inclusion of feed additives in livestock diets or supplements is a routine global nutritional management practice. Consequently, the existing commercial feed additive marketing and delivery pathways will be able to deliver rapid market penetration of feed additives specifically developed to reduce enteric methane emissions. So, the delivery path is clear, but are the methane mitigating additives available, effective, and are there any constraints or risks associated with their use? To answer these questions an assessment of the ten leading classes of compounds being studied for methane mitigation efficacy in ruminants was made. The assessment is provided as a concise resource that can serve as an evidence base to guide investment and management decisions by all actors in the livestock additive supply chain

MerTK inhibition in tumor leukocytes decreases tumor growth and metastasis

MerTK, a receptor tyrosine kinase (RTK) of the TYRO3/AXL/MerTK family, is expressed in myeloid lineage cells in which it acts to suppress proinflammatory cytokines following ingestion of apoptotic material. Using syngeneic mouse models of breast cancer, melanoma, and colon cancer, we found that tumors grew slowly and were poorly metastatic in MerTK–/– mice. Transplantation of MerTK–/– bone marrow, but not wild-type bone marrow, into lethally irradiated MMTV-PyVmT mice (a model of metastatic breast cancer) decreased tumor growth and altered cytokine production by tumor CD11b+ cells. Although MerTK expression was not required for tumor infiltration by leukocytes, MerTK–/– leukocytes exhibited lower tumor cell–induced expression of wound healing cytokines, e.g., IL-10 and growth arrest-specific 6 (GAS6), and enhanced expression of acute inflammatory cytokines, e.g., IL-12 and IL-6. Intratumoral CD8+ T lymphocyte numbers were higher and lymphocyte proliferation was increased in tumor-bearing MerTK–/– mice compared with tumor-bearing wild-type mice. Antibody-mediated CD8+ T lymphocyte depletion restored tumor growth in MerTK–/– mice. These data demonstrate that MerTK signaling in tumor-associated CD11b+ leukocytes promotes tumor growth by dampening acute inflammatory cytokines while inducing wound healing cytokines. These results suggest that inhibition of MerTK in the tumor microenvironment may have clinical benefit, stimulating antitumor immune responses or enhancing immunotherapeutic strategies

Genomic, Pathway Network, and Immunologic Features Distinguishing Squamous Carcinomas

This integrated, multiplatform PanCancer Atlas study co-mapped and identified distinguishing molecular features of squamous cell carcinomas (SCCs) from five sites associated with smokin

Genome-Wide Association Analysis Identifies a Mutation in the Thiamine Transporter 2 (SLC19A3) Gene Associated with Alaskan Husky Encephalopathy

Alaskan Husky Encephalopathy (AHE) has been previously proposed as a mitochondrial encephalopathy based on neuropathological similarities with human Leigh Syndrome (LS). We studied 11 Alaskan Husky dogs with AHE, but found no abnormalities in respiratory chain enzyme activities in muscle and liver, or mutations in mitochondrial or nuclear genes that cause LS in people. A genome wide association study was performed using eight of the affected dogs and 20 related but unaffected control AHs using the Illumina canine HD array. SLC19A3 was identified as a positional candidate gene. This gene controls the uptake of thiamine in the CNS via expression of the thiamine transporter protein THTR2. Dogs have two copies of this gene located within the candidate interval (SLC19A3.2 – 43.36–43.38 Mb and SLC19A3.1 – 43.411–43.419 Mb) on chromosome 25. Expression analysis in a normal dog revealed that one of the paralogs, SLC19A3.1, was expressed in the brain and spinal cord while the other was not. Subsequent exon sequencing of SLC19A3.1 revealed a 4bp insertion and SNP in the second exon that is predicted to result in a functional protein truncation of 279 amino acids (c.624 insTTGC, c.625 C>A). All dogs with AHE were homozygous for this mutation, 15/41 healthy AH control dogs were heterozygous carriers while 26/41 normal healthy AH dogs were wild type. Furthermore, this mutation was not detected in another 187 dogs of different breeds. These results suggest that this mutation in SLC19A3.1, encoding a thiamine transporter protein, plays a critical role in the pathogenesis of AHE.University of California, Davis. School of Veterinary Medicine. Center for Companion Animal Healt